Arvelle Therapeutics Competitors and Similar CompaniesClear all
Arvelle Therapeutics's competitors and similar companies include InhibRx, Dyne Therapeutics, Meissa Vaccines and Secura Bio.
 InhibRx InhibRx is a clinical-stage biotechnology company developing a broad pipeline of novel biologic therapeutic candidates. |  Dyne Therapeutics Dyne Therapeutics is a biotechnology company which is engaged in the development of targeted therapies for patients with serious muscle diseases. |  Meissa Vaccines Meissa Vaccines is a pharmaceutical company focused on the advancement of unmet vaccines against viruses that cause serious human diseases, such as a respiratory syncytial virus. |  Secura Bio Secura Bio is an integrated biopharmaceutical company dedicated to the commercialization of oncology therapies. | ||
Founding Date | Founding Date 2019 | Founding Date 2017 | Founding Date 2018 | Founding Date 2014 | Founding Date 2019 |
Type | Type Subsidiary | Type Public | Type Public | Type Private | Type Private |
Tags | |||||
Locations | Locations Zug, CH HQ Zug, CH | Locations San Diego, US HQ | Locations Waltham, US HQ | Locations South San Francisco, US HQ Redwood City, US | Locations Las Vegas, US HQ San Diego, US |
Employees | Employees 10 | Employees 1531% increase | Employees 1451% decrease | Employees 3 | Employees 489% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) 233.1 m | Valuation ($) 3.1 b | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||
Net income | Net income N/A | Net income ($241.4m) (FY, 2023) | Net income ($446.2m) (FY, 2025) | Net income N/A | Net income N/A |
Funding | |||||
Latest funding round | Latest funding round N/A | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 30m (over 6 years ago) | Latest funding round $ 55m (about 7 years ago) |
Total funding raised | Total funding raised $ 180m | Total funding raised $ 43.6m | Total funding raised $ 165m | Total funding raised $ 33.4m | Total funding raised $ 195m |
For sources of this data, please see the company profile
View Company Profiles
InhibRx
HQ
San Diego, US
Employees
153↑ 1% increase
InhibRx is a clinical-stage biotechnology company developing a broad pipeline of novel biologic therapeutic candidates.
View companyDyne Therapeutics
HQ
Waltham, US
Employees
145↓ 1% decrease
Dyne Therapeutics is a biotechnology company which is engaged in the development of targeted therapies for patients with serious muscle diseases.
View companyMeissa Vaccines
HQ
South San Francisco, US
Employees
3
Meissa Vaccines is a pharmaceutical company focused on the advancement of unmet vaccines against viruses that cause serious human diseases, such as a respiratory syncytial virus.
View companySecura Bio
HQ
Las Vegas, US
Employees
48↑ 9% increase
Secura Bio is an integrated biopharmaceutical company dedicated to the commercialization of oncology therapies.
View company